Azerbaijan
Diabetes country report 2011 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Azerbaijan (AZ)
2011 | 167.1 thousand |
2024 | 715.3 thousand |
2050 | 1.0 million |
Azerbaijan is one of the 60 countries and territories in the IDF Europe Region.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPs Azerbaijan 2017
2000
2011
2024
2050
Loading...
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | - | 167.1 | 715.3 | 1,025.4 |
Age-standardised prevalence of diabetes, % | - | 2.8 | 10.2 | 11.7 |
Proportion of people with undiagnosed diabetes, % | - | - | 33.9 | - |
People with undiagnosed diabetes, in 1,000s | - | 60.0 | 242.5 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 387.4 | 502.4 |
Age-standardised prevalence of IFG, % | - | - | 5.3 | 5.8 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 591.5 | 222.9 | 248.2 |
Age-standardised prevalence of IGT, % | - | 9.5 | 3.1 | 2.8 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 2,735.0 | 4,378.7 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 9.2 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 346.1 | 421.2 |
Total diabetes-related health expenditure, ID million | - | - | 1,322.6 | 1,609.7 |
Diabetes-related health expenditure per person, USD | - | 366.0 | 483.8 | 410.8 |
Diabetes-related health expenditure per person, ID | - | - | 1,849.2 | 1,569.9 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 9,533.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 2,178.8 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | - | 6,398.9 | 7,239.2 | 8,123.8 |
Population of children and adolescents (0-19 y) | - | - | 3,015,815.5 | - |
Loading...
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | - |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | - |
Population of children and adolescents (0-19 y) | - |